Silverberg Bernstein Capital Management’s Apyx Medical APYX Stock Holding History
Bought
Maintained
Sold
Other funds holding APYX
ACM
Silverberg Bernstein Capital Management's APYX Position: Q3 2026 in Review
Silverberg Bernstein Capital Management reduced its Apyx Medical (APYX) stake by 1.7% in Q3 2026, selling an estimated $60.8K and leaving 1,022,239 shares worth $2.5M. The position accounts for 1.18% of the portfolio, ranked #21.
Silverberg Bernstein Capital Management first reported a position in APYX in Q4 2023 and has held it in 12 quarters since. The position peaked at $4.67M in Q2 2026. 69 funds tracked by Wall St. Rank hold APYX as of Q3 2026.
- Silverberg Bernstein Capital Management held 1,022,239 shares of Apyx Medical worth $2.5M as of Q3 2026.
- Silverberg Bernstein Capital Management sold 17,402 Apyx Medical shares in Q3 2026, an estimated $60.8K.
- Apyx Medical made up 1.18% of Silverberg Bernstein Capital Management's portfolio in Q3 2026, its #21 holding.
- Silverberg Bernstein Capital Management first reported a position in Apyx Medical in Q4 2023 and has held it in 12 quarters since.
- Silverberg Bernstein Capital Management's Apyx Medical position peaked at $4.67M in Q2 2026.
- 69 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2026.
Based on Silverberg Bernstein Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.